ELF3 overexpression is significantly linked to poor outcomes in hepatocellular, colorectal cancer, and lung adenocarcinoma patients, and that ELF3 enhance cell growth, migration in these cancers.39, 40, 41, 42. The gene discussed is ELF3; the disease is cancer.